1. Home
  2. COEP vs PETS Comparison

COEP vs PETS Comparison

Compare COEP & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • PETS
  • Stock Information
  • Founded
  • COEP 2017
  • PETS 1996
  • Country
  • COEP United States
  • PETS United States
  • Employees
  • COEP N/A
  • PETS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • COEP Health Care
  • PETS Consumer Staples
  • Exchange
  • COEP Nasdaq
  • PETS Nasdaq
  • Market Cap
  • COEP 65.8M
  • PETS 70.4M
  • IPO Year
  • COEP N/A
  • PETS N/A
  • Fundamental
  • Price
  • COEP $12.74
  • PETS $3.08
  • Analyst Decision
  • COEP
  • PETS Sell
  • Analyst Count
  • COEP 0
  • PETS 1
  • Target Price
  • COEP N/A
  • PETS $3.20
  • AVG Volume (30 Days)
  • COEP 44.3K
  • PETS 126.5K
  • Earning Date
  • COEP 08-14-2025
  • PETS 11-03-2025
  • Dividend Yield
  • COEP N/A
  • PETS N/A
  • EPS Growth
  • COEP N/A
  • PETS N/A
  • EPS
  • COEP N/A
  • PETS 0.02
  • Revenue
  • COEP $263,555.00
  • PETS $247,010,000.00
  • Revenue This Year
  • COEP N/A
  • PETS N/A
  • Revenue Next Year
  • COEP N/A
  • PETS N/A
  • P/E Ratio
  • COEP N/A
  • PETS $181.38
  • Revenue Growth
  • COEP N/A
  • PETS N/A
  • 52 Week Low
  • COEP $2.31
  • PETS $2.81
  • 52 Week High
  • COEP $14.70
  • PETS $6.85
  • Technical
  • Relative Strength Index (RSI)
  • COEP 56.79
  • PETS 48.27
  • Support Level
  • COEP $12.50
  • PETS $3.05
  • Resistance Level
  • COEP $14.09
  • PETS $3.26
  • Average True Range (ATR)
  • COEP 0.92
  • PETS 0.16
  • MACD
  • COEP -0.08
  • PETS 0.02
  • Stochastic Oscillator
  • COEP 55.49
  • PETS 65.90

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: